Chief Minister BS Yediyurappa virtually inaugurated Phase 3 of a clinical trial of Covaxin being developed by Bharat Biotech. The trials will be conducted at Vydehi Institute of Medical Sciences and Research Centre in Bengaluru.
The Phase-III clinical trial of Covid-19 vaccine – Covaxin being developed by Bharat Biotech began at the privately-run Vydehi multi-specialty hospital in Bengaluru. Covaxin’ is being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
I think they’re doing a clinical trial on about 1600-1800 people in Karnataka. CM has officially announced & given the first dose today through the Vydehi institution. I hope the 3rd phase will be very successful & will be devoid of adverse effects on any individual, Health Minister K Sudhakar told ANI.
Earlier, Vydehi Institute of Medical Sciences and Research Centre official K. Ravi Babu told IANS. “The ICMR (Indian Council of Medical Research) has permitted our hospital to conduct the third phase trial for Covaxin developed by the Hyderabad-based Bharat Biotech.
The hospital has roped in Clintrac International Ltd for the trials, which will involve about 1,000 volunteers.
Though the volunteers need not stay in the hospital, Babu said they would be monitored daily through phone/video call for feedback and updates.